NCP Inc. Acquires 2,245 Shares of Omega Healthcare Investors, Inc. (NYSE:OHI)

NCP Inc. grew its stake in shares of Omega Healthcare Investors, Inc. (NYSE:OHI) by 67.8% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 5,555 shares of the real estate investment trust’s stock after buying an additional 2,245 shares during the period. NCP Inc.’s holdings in Omega Healthcare Investors were worth $226,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds have also recently modified their holdings of OHI. BNP Paribas Financial Markets increased its holdings in Omega Healthcare Investors by 120.8% in the 3rd quarter. BNP Paribas Financial Markets now owns 226,338 shares of the real estate investment trust’s stock valued at $9,212,000 after acquiring an additional 123,836 shares during the last quarter. FMR LLC increased its holdings in shares of Omega Healthcare Investors by 9.9% in the third quarter. FMR LLC now owns 4,216,835 shares of the real estate investment trust’s stock worth $171,625,000 after purchasing an additional 380,626 shares during the last quarter. Bank of Montreal Can lifted its position in shares of Omega Healthcare Investors by 309.7% in the third quarter. Bank of Montreal Can now owns 267,394 shares of the real estate investment trust’s stock worth $10,784,000 after buying an additional 202,131 shares in the last quarter. Truvestments Capital LLC bought a new position in Omega Healthcare Investors during the third quarter valued at approximately $43,000. Finally, Loomis Sayles & Co. L P purchased a new position in Omega Healthcare Investors during the 3rd quarter valued at approximately $47,000. Hedge funds and other institutional investors own 65.25% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on OHI. Berenberg Bank assumed coverage on Omega Healthcare Investors in a report on Friday, October 18th. They set a “buy” rating and a $45.00 price objective on the stock. Wells Fargo & Company reissued an “overweight” rating and set a $43.00 price objective (up from $40.00) on shares of Omega Healthcare Investors in a research note on Tuesday, October 1st. BNP Paribas raised Omega Healthcare Investors from a “neutral” rating to an “outperform” rating and set a $49.00 price objective for the company in a research note on Thursday, October 31st. Scotiabank increased their price target on Omega Healthcare Investors from $33.00 to $39.00 and gave the company a “sector perform” rating in a report on Monday, August 26th. Finally, Royal Bank of Canada raised their price target on Omega Healthcare Investors from $39.00 to $43.00 and gave the stock a “sector perform” rating in a research report on Monday, November 11th. Seven equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $40.00.

Omega Healthcare Investors Price Performance

Omega Healthcare Investors stock opened at $40.77 on Wednesday. The stock has a market cap of $11.01 billion, a price-to-earnings ratio of 29.98, a price-to-earnings-growth ratio of 1.25 and a beta of 0.99. The firm has a 50-day moving average of $40.61 and a two-hundred day moving average of $37.19. Omega Healthcare Investors, Inc. has a 1 year low of $27.53 and a 1 year high of $44.42. The company has a debt-to-equity ratio of 1.10, a current ratio of 6.48 and a quick ratio of 6.48.

Omega Healthcare Investors Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Monday, November 4th were paid a dividend of $0.67 per share. The ex-dividend date was Monday, November 4th. This represents a $2.68 annualized dividend and a dividend yield of 6.57%. Omega Healthcare Investors’s dividend payout ratio is currently 197.06%.

Insider Activity at Omega Healthcare Investors

In other news, COO Daniel J. Booth sold 56,725 shares of the business’s stock in a transaction dated Friday, September 27th. The shares were sold at an average price of $40.25, for a total value of $2,283,181.25. Following the completion of the sale, the chief operating officer now owns 100,000 shares in the company, valued at approximately $4,025,000. The trade was a 36.19 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CFO Robert O. Stephenson sold 22,542 shares of the stock in a transaction that occurred on Friday, September 27th. The shares were sold at an average price of $40.19, for a total transaction of $905,962.98. Following the transaction, the chief financial officer now owns 183,076 shares in the company, valued at approximately $7,357,824.44. This represents a 10.96 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.37% of the stock is currently owned by corporate insiders.

Omega Healthcare Investors Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.